Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.
Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.
Summary not available.
Summary not available.
Henry Schein, Inc. (NASDAQ: HSIC) launched its 24th annual ‘Back to School’ program, providing backpacks filled with supplies to nearly 4,500 children across 22 locations in the U.S., Canada, Spain, and Ireland. Since 1998, the initiative has supported over 60,000 children. The program underscores the company's commitment to corporate social responsibility through Henry Schein Cares. Executive VP Gerry Benjamin highlighted the program's adaptability during the pandemic, emphasizing the importance of helping children return to school with confidence.
Henry Schein, Inc. has appointed Graham Stanley as Vice President of Investor Relations and Strategic Financial Project Officer. Graham will enhance communications with investors and oversee key financial initiatives. With extensive experience in finance management, he previously served as CFO of Henry Schein's Global Dental Group. The company, a leader in health care solutions, operates globally, serving over 1 million customers. In 2020, Henry Schein generated $10.1 billion in sales, growing at a compound annual rate of approximately 12% since becoming public in 1995.
Henry Schein, Inc. (NASDAQ: HSIC) has announced a new organizational structure to enhance operational efficiency and customer experience in the dental and medical distribution sectors. The company will establish two key groups: the North America Distribution Group and the International Distribution Group, led by seasoned executives. Additionally, three specialty product areas will focus on higher-margin markets, including Henry Schein One for dental software solutions. The changes will not incur restructuring charges and aim to leverage functions and processes across the business.
Summary not available.
Henry Schein, Inc. (NASDAQ: HSIC), the leading provider of healthcare solutions, announced its participation in two investor conferences in September 2021. The company will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021, at 1:15 p.m. ET, and the Baird 2021 Virtual Global Healthcare Conference on September 14, 2021, at 12:50 p.m. ET. Live webcasts will be available on the company's website, with replays accessible afterward. Henry Schein serves over 1 million customers globally, emphasizing operational success and clinical outcomes.
Henry Schein Medical has been named the 'Official Sports Medicine Partner' of the National Association of Intercollegiate Athletics (NAIA) until June 2022. This partnership offers NAIA members discounted sports medicine services, enhancing medical support for student-athletes across campuses. Henry Schein will also provide training supplies for NAIA Championships, emphasizing their commitment to athlete care. The partnership is seen as a significant addition to NAIA’s services, aiming to improve health care access within collegiate sports.
Summary not available.
Henry Schein (Nasdaq: HSIC) has amended its revolving credit facility, increasing the borrowing limit from $750 million to $1 billion and extending the facility through August 2026. This initiative, supported by JP Morgan Securities and U.S. Bank, aims to enhance financial flexibility for the company's strategic plans, including internal growth and acquisitions. The announcement highlights the commitment to optimizing capital allocation to support long-term growth strategies.